Get research updatesDepression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.
This study evaluated the safety of Lumateperone for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including PhoenixResearchers studied ANC-501 to find out how it affected depression symptoms in adults with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including OrangeEXPERIMENTAL ANTIVIRAL TREATMENT OF CYTOMEGALOVIRUS IN DEPRESSION: AFFECTIVE, NEURAL, AND INFLAMMATORY MECHANISMS
This study has finished and is no longer accepting participants.
In Tulsa
Assessment of Transcultural Psychotherapy to Treat Major Depressive Disorder in Children and Adolescents From Migrant Families: a Bayesian Randomized Controlled Trial
This study is no longer accepting new participants.
Multiple locations, including Bobigny
Feasibility of Using Alpha Phase-Locked Auditory Stimulation for Insomnia Symptoms in People With Depression
This study was withdrawn before enrollment.
In Winston-SalemAugmenting Single-session Behavioral Activation (BA) With Delta-beta Transcranial Alternating Current Stimulation (tACS) for the Treatment of Depression
This study has finished and is no longer accepting participants.
In Chapel HillThérapie Avatar Pour le Traitement du Trouble dépressif caractérisé réfractaire : Une étude Pilote
This study is no longer accepting new participants.
In MontrealAdapted Tele-Behavioral Activation Targeted to Increase Physical Activity in Depression
This study has finished and is no longer accepting participants.
In Dallas
This study has finished and is no longer accepting participants.
Multiple locations, including BostonBIOMARKERS FOR DRUG SELECTION IN DEPRESSION: 3BD Test
This study has finished and is no longer accepting participants.
In Buenos AiresBlended Care Psychodynamic Therapy or Cognitive Behavioral Therapy Versus Face-to-Face Psychotherapy for Depression: A Pragmatic Multicenter Randomized Controlled Non-inferiority Trial
This study is no longer accepting new participants.
Multiple locations, including BerchemProtocol 331-13-004: An Exploratory, Multicenter, Single-blind, fMRI Study of Fixed-dose Brexpiprazole (OPC 34712) (2 mg/Day Tablets) as an Adjunctive Treatment
This study was withdrawn before enrollment.
In AtlantaWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.